Skip to search formSkip to main contentSkip to account menu

Rebif

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Orphan Nano drugs such as Rituxan, Revlimid, Soliris, Afinitor, Tasigna, Velcade, Avonex, Alimta, Yervoy, Sprycel, Rebif… 
2015
2015
Background: Multiple Sclerosis (MS) is the most common chronic inflammatory autoimmune disease of central nervous system that is… 
2015
2015
Nowadays, demyelinating diseases of the central nervous system form a large nosological group in which multiple sclerosis takes… 
2012
2012
Authors have followed up 230 patients with multiple sclerosis treated with disease modifying drugs (DMD) using the data of the… 
2011
2011
We summarized the 3-year experience of using beta-interferon 1a (44 mcg, subcutaneously) in the form of the preparation rebif in… 
Review
2009
Review
2009
therapy for multiple sclerosis (MS) that can both slow disease progression and reduce clinical exacerbations. Studies have… 
2005
2005
The administration of β-interferon is a recognized treatment for multiple sclerosis. The frequency of side effects is an… 
2003
2003
The results of multicenter study of Rebif 22 micrograms in Russia have been reported. 167 multiple sclerosis patients have…